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Objective: Tracheal reconstruction is necessary in patients with extensive
tracheal stenosis caused by neoplasm, trauma, and congenital disease. We
investigated the possibility of tracheal allotransplantation with cryopre-
served grafts in a canine model. Methods: A seven-ring section of thoracic
trachea was removed in 19 adult mongrel dogs. In group A (n 5 4), a
five-ring tracheal autograft was implanted. In group B (n 5 6), a five-ring
allograft was implanted without immunosuppression. In group C (n 5 9),
a five-ring cryopreserved tracheal allograft was implanted without immu-
nosuppression. Omentopexy wrapping around the grafts and both anasto-
motic sites was used in all animals. Results: All grafts survived without any
evidence of atrophy or stenosis in group A. All animals in group B died of
severe airway obstruction within 1 month, and postmortem examination of
these grafts showed epithelial defect and necrotic tracheal cartilage in the
scar tissue. In group C, no animals died of asphyxia caused by severe
stenosis of the grafts. The graft epithelium was no longer present 20 days
after transplantation, and the graft was covered with regenerated epithe-
lium within about 60 days after the operation. Conclusion: These findings
show that cryopreserved tracheal allografts can be transplanted by means
of omentopexy without immunosuppression and that cryopreservation may
reduce tracheal allogenicity. (J Thorac Cardiovasc Surg 1998;116:262-6)
Tracheal reconstruction is necessary in patientswith extensive tracheal stenosis caused by neo-
plasm, trauma, and congenital disease. Experimen-
tally, the reconstruction of a long defect of the
thoracic trachea by allotransplantation has been
reported to be possible with the aid of immunosup-
pressive agents and omentopexy.1 Date2 previously
reported that tracheal autografts could be preserved
for up to 48 hours in Euro-Collins solution. How-
ever, a more long-term tracheal preservation period
is necessary to solve the shortage of organ donors.
We believe that tracheal cryopreservation is the best
method for this, and we obtained satisfactory results
in tracheal reconstruction with a cryopreserved al-
lograft without immunosuppression.
Material and methods
Experimental design. Nineteen adult mongrel dogs,
weighing 8 to 16 kg, were used. In group A (autotrans-
plantation; n 5 4), a section of seven rings of thoracic
trachea was removed and five rings of trachea were
immediately reimplanted. In group B (n 5 6), a section of
the thoracic trachea of the same length was allotrans-
planted with five rings of trachea immediately after har-
vest. In group C (n 5 9), allotransplantation was per-
formed with grafts that had been cryopreserved for more
than 20 days. Omentopexy was performed in all groups,
and immunosuppressive agents and steroids were not used
after the operation in any group.
Harvest of grafts. Each animal was anesthetized with
intramuscular ketamine (10 mg/kg), intravenous sodium
pentobarbital (30 mg/kg), and pancuronium bromide
(2 mg).
The animals were orally intubated and connected to a
volume-limited respirator (a tidal volume of 20 ml/kg and
a frequency of 20 breaths/min). Anesthesia was main-
tained with 50% oxygen, 50% nitrous oxide, and 1%
halothane. The animals were placed in the lateral decub-
itus position and the chest was opened via a right thora-
cotomy through the right fourth intercostal space. The
thoracic trachea was dissected and seven tracheal rings
were excised in continuity.
Cryopreservation. In group C, the section of seven
tracheal rings excised from the donor animal was im-
mersed in a preservative solution at 4° C for 4 hours. The
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preservation solution consisted of Dulbecco’s modified
Eagle’s medium (Gibco, Grand Island Biological Com-
pany, New York, N.Y.), 20% fetal calf serum, 10%
dimethyl sulfoxide, and a 0.1 mol/L concentration of
sucrose. A CELL FREEZE bag (7039-2, CharterMed
Inc., Lakewood, N.J.) containing the trachea was filled
with the preservative solution and sealed. The bag was
surrounded with cotton, placed in a plastic case, and the
case was frozen at – 80° C for 24 hours. The bag was
then stored in gaseous liquid nitrogen (–196° C) for 20
more days. The cryopreserved trachea was thawed
rapidly in a water bath maintained at 37° C before
transplantation.
Transplantation procedure. Recipient dogs were anes-
thetized in the same way as donor animals. Animals were
placed in the left semidecubitus position, and a right
thoracotomy was performed. After the azygos vein was
ligated and transected, the thoracic trachea was isolated
and seven tracheal rings were removed. Tracheal continu-
ity was restored by insertion of the tracheal graft with five
rings and over-and-over continuous 4-0 Prolene suture
(Ethicon, Inc., Somerville, N.J.). The grafts were sutured
by the telescopic method so that both the central and
peripheral portions could be positioned correctly. After
completion of the anastomoses, the omental pedicle was
brought into the right hemithorax through an incision in
the right hemidiaphragm and wrapped around the graft,
including both anastomotic sites.
Postoperative follow-up. Postoperatively, animals re-
ceived intramuscular antibiotics for the first 3 days. No
immunosuppressive agents or steroids were given.
Follow-up bronchoscopic studies were performed weekly
for a month to examine graft viability. When animals died
or were put to death, the transplanted graft and three
rings of recipient trachea from the anastomotic site were
excised in continuity and examined grossly and microscop-
ically.
All animals received humane care in compliance with
the “Principles of Laboratory Animal Care” formulated
by the National Society for Medical Research and the
“Guide for the Care and Use of Laboratory Animals”
prepared by the Institute of Laboratory Animal Resources
and published by the National Institutes of Health (NIH
publication No. 86-23, revised 1985).
Results
In group A (Table I), three animals were put to
death on days 7, 50, and 123 after transplantation
and one died of prostration caused by diarrhea on
day 335. That dog survived the longest of any of the
study animals. All four autografts, however, proved
to be viable, with almost normal tracheal structure,
and were free of granulation tissue or a stricture
(Fig. l, A). Histologic examination showed
pseudostratified columnar ciliary epithelium, viable
subepithelial tissue, and normal cartilage (Fig. 1, B).
In group B (Table II), four animals died of
asphyxia within 1 month because of severe stenosis
of the airway caused by extreme shrinkage of the
grafts (Fig. 2, A). Histologic examination revealed
epithelial defects, granulation tissue with fibrosis,
mononuclear cell infiltration into the subepithelium,
and absorption of tracheal cartilage (Fig. 2, B). One
animal was put to death on day 7 after transplanta-
tion, and its allograft showed relatively normal
appearing ciliary epithelium, normal subepithelial
tissue, and normally shaped cartilage without cell
infiltration. The allograft taken from one animal
that died of prostration 15 days after the operation
showed degeneration and necrosis of the tracheal
epithelium and cartilage.
In group C (Table III), no animal died of asphyxia
due to severe stenosis of the airway caused by
extreme shrinkage of the graft. The follow-up after
transplantation was from 10 to 206 days. Four
animals were put to death, three died of other
complications, and two remain alive. The causes of
death were prostration resulting from continuous
diarrhea and anorexia in two dogs and respiratory
failure owing to pneumonia in one. The allograft
taken from one animal killed 10 days after the
operation (dog 8) appeared almost normal. The
epithelium had histologically pseudostratified co-
lumnar features without cilia, but subepithelial tis-
sue was viable and the cartilage maintained its
shape. The allografts from animals that were killed or
that died in less than 30 days after the operation (dogs
4, 5, and 6) had no epithelium histologically, but
mononuclear cell infiltration was limited and viability
of the tracheal cartilage and the subepithelial
Table I. Results of tracheal autotransplantation
(group A)
Dog
No.
Time
(days) Outcome Graft status Cause of death
1 7 Put to death Viable
2 50 Put to death Viable
3 123 Put to death Viable
4 335 Died Viable Diarrhea
Table II. Results of tracheal allotransplantation
(group B)
Dog
No.
Time
(days) Outcome Graft status Cause of death
1 7 Put to death Viable
2 15 Died Partial necrosis Prostration
3 20 Died Necrosis Asphyxia
4 24 Died Necrosis Asphyxia
5 25 Died Necrosis Asphyxia
6 28 Died Necrosis Asphyxia
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tissue was preserved. The allografts from animals
put to death 46 and 53 days after the operation
(dogs 1 and 2) showed partially defective epithe-
lium. Pseudostratified columnar ciliary epithelium
was observed near the anastomotic site, but one
epithelial layer without cilia was present next to
an epithelial defect. Neither mononuclear cell
infiltration nor resorption of tracheal cartilage
was observed. The grafts taken from the animal
that survived more than 70 days (dog 7) showed
normal tracheal architecture (Fig. 3, A). Histo-
logic examination revealed that the mucosa was
composed of pseudostratified columnar ciliary
epithelium and the tracheal secretory glands were
regenerated. The cartilaginous matrix was intact,
the cells were viable in the lacunae of the carti-
lage, and infiltration by mononuclear cells was not
observed (Fig. 3, B). In all cryopreserved allo-
grafts, however, cartilage segments showed the
loss of chondrocyte nuclei in the lacunae and poor
staining reaction of the lacunae.
Discussion
Many experiments have been performed to
reconstruct tracheal defects by transplantation
and to examine donor tracheal preservation. Pre-
vious experiments in our laboratory showed satis-
factory results with the use of omentopexy and
immunosuppression for tracheal allotransplanta-
tion1 and also showed that tracheal autografts
could be preserved for up to 48 hours in Euro-
Collins solution.2 Before tracheal transplantation
can be applied clinically, however, the problem of
the shortage of organ donors must be solved. A
more long-term preservation of trachea will be
necessary to help accomplish this. Cryopreserva-
tion has been shown to be a useful technique for
storing isolated organs, and cryopreservation of
cardiac valves and cartilage has already had clin-
ical success.3, 4 Histologic examination of cryopre-
served canine tracheal tissue has shown normal
epithelium, smooth muscle, and ciliary function.5
A long tracheal defect that incorporates 50% of
the tracheal circumference can be repaired with a
cryopreserved cartilaginous allograft,6 and it is
possible to autotransplant trachea cryopreserved
in a preservative solution containing trehalose.7
Fig. 1. A, Gross examination shows good graft acceptance. No stenosis or signs of necrosis are seen in the
graft. B, Histologic examination shows pseudostratified columnar ciliary epithelium, viable subepithelial
tissue, and normal cartilage. (Hematoxylin-eosin stain; original magnification 3100.)
Table III. Results of tracheal allotransplantation
with cryopreserved graft (group C)
Dog
No.
Time
(days) Outcome
Graft
status
Cause
of
death
Preservation
time
(days)
1 53 Put to death Viable 14
2 46 Put to death Viable 21
3 206 Alive Viable 150
4 20 Put to death Viable 76
5 26 Died Viable Pneumonia 34
6 27 Died Viable Prostration 34
7 70 Died Viable Prostration 20
8 10 Put to death Viable 80
9 58 Alive Viable 133
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The application of these techniques to tracheal
allotransplantation seems logical.
Kawabe and Yoshinao8 showed a difference in the
survival of chondrocytes by changing the concentra-
tion and time of exposure to dimethyl sulfoxide.
They concluded that the best technique used is 10%
dimethyl sulfoxide and an exposure at 4° C for 4
hours. In the present study, the tracheal grafts were
exposed to 10% dimethyl sulfoxide at 4° C for 4
hours before cryopreservation.
In the present study, cryopreserved tracheal allo-
grafts survived with no evidence of stenosis, and
they remained sufficiently rigid to keep the lumen
completely open. The subepithelial tissue and the
tracheal cartilage were viable histologically in all
cryopreserved tracheal allografts. Although three
Fig. 2. A, The graft shows the severe stenosis caused by extreme shrinkage. B, Histologic examination
reveals defective epithelium and necrotic tracheal cartilage in the scar tissue. (Hematoxylin-eosin stain;
original magnification 3100.)
Fig. 3. A, Gross examination shows normal tracheal architecture as seen in Fig. 1, A. No stenosis of the
graft is seen. B, Histologic examination shows that the mucosa is composed of pseudostratified columnar
ciliary epithelium and regeneration of the tracheal secretory glands. The cartilaginous matrix is intact, and
the cells are viable in the lacunae of the cartilage. (Hematoxylin-eosin stain; original magnification 3100.)
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animals died of other complications in group C,
the causes of these deaths are not related to
problems with the allografts. The allograft epithe-
lium is no longer present 20 days after transplan-
tation and is gradually regenerated from the
anastomotic site at the recipient trachea. The
allograft was covered with regenerated epithelium
within about 60 days after the operation. We
believe the origin of the regenerated epithelium in
the cryopreserved allograft is from the recipient
tracheal epithelium, which we are studying by
genetic methods in our laboratory.
In the present study, animals undergoing tra-
cheal allotransplantation with cryopreserved
grafts did not need immunosuppressive agents
after the operation, which suggests that tracheal
transplantation can be extended to tracheal ste-
nosis caused not only by benign disease, trauma,
or congenital disease, but also by a malignant
neoplasm. However, the antigenicity of tracheal
transplants is not completely known. Gertzbein
and associates9 suggested that chondrocytes have
tissue-specific antigen on their surfaces and that
these cells are surrounded by a weakly antigenic
matrix that acts as a biologic barrier to protect the
chondrocytes. Bujia and associates10 demon-
strated HLA class II subregion gene products on
human tracheal epithelium and mixed glandular
tissue; they concluded that tracheal mucosa may
be the major antigenic structure of the trachea
and may be responsible for the immunogenic
action of tracheal allotransplants. The present
study showed a loss of chondrocyte nuclei and the
poor staining reaction in the matrix after cryo-
preservation. It also showed that the epithelium of
the cryopreserved allograft was no longer present
after transplantation. These facts may be relevant
to the decrease of cryopreserved allograft antige-
nicity, or cryopreservation itself may decrease the
antigenicity of the trachea.
We conclude that cryopreserved tracheal allograft
can be transplanted by means of omentopexy with-
out immunosuppression. We believe, however, that
more long-term follow-up is necessary to determine
the possibility of progressive rejection. Further in-
vestigation of antigenicity is also necessary before
our method can be applied clinically.
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